| 000 | 01485 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250515201659.0 | ||
| 264 | 0 | _c20100226 | |
| 008 | 201002s 0 0 eng d | ||
| 022 | _a1873-5576 | ||
| 024 | 7 |
_a10.2174/156800909789760249 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLin, J | |
| 245 | 0 | 0 |
_aHIF-1alpha and calcium signaling as targets for treatment of prostate cancer by cardiac glycosides. _h[electronic resource] |
| 260 |
_bCurrent cancer drug targets _cNov 2009 |
||
| 300 |
_a881-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aCalcium Signaling _xdrug effects |
| 650 | 0 | 4 |
_aCardiac Glycosides _xpharmacology |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoxia _xmetabolism |
| 650 | 0 | 4 |
_aHypoxia-Inducible Factor 1, alpha Subunit _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aReceptor Cross-Talk |
| 650 | 0 | 4 |
_aReceptors, Androgen _xmetabolism |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 700 | 1 | _aDenmeade, S | |
| 700 | 1 | _aCarducci, M A | |
| 773 | 0 |
_tCurrent cancer drug targets _gvol. 9 _gno. 7 _gp. 881-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/156800909789760249 _zAvailable from publisher's website |
| 999 |
_c19406342 _d19406342 |
||